Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Immunology|March 25, 2014
Susceptibility quantitative trait loci for pathogenic leucocytosis in SCG/Kj mice, a spontaneously occurring crescentic glomerulonephritis and vasculitis modelY Hamano, M Abe, S Matsuoka, et al.
Experimental Hematology|November 10, 1998
Analysis of bax protein in sphingosine-induced apoptosis in the human leukemic cell line TF1 and its bcl-2 transfectantsC Isogai, T Murate, K Tamiya-Koizumi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study GroupM Ogura, Y Kagami, R Suzuki, et al.
British Journal of Haematology|December 19, 1998
Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virusY Kagami, S Nakamura, R Suzuki, et al.
International Journal of Hematology|October 1, 1996
Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16. MST-16 Study GroupY Kagami, Y Ariyoshi, A Horiuchi, et al.
International Journal of Hematology|May 25, 2001
Re-treatment of relapsed indolent B-cell lymphoma with rituximabT Igarashi, T Ohtsu, H Fujii, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2005
Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphomaK Tanimoto, A Kaneko, S Suzuki, et al.
Histopathology|May 12, 2007
Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphomaN Asano, R Suzuki, K Matsuo, et al.
Blood|October 6, 1997
CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entityR Suzuki, K Yamamoto, M Seto, et al.
Leukemia|September 14, 1999
Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypesS Harada, R Suzuki, K Uehira, et al.
Pageof 12